Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model

The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been identified as the prime target for vaccine development. The spike protein mediates both binding to host cells and membrane fusion and is also so far the only known viral target of neutralizing antibodies. Coro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:bioRxiv
Main Authors: Amanat, Fatima, Strohmeier, Shirin, Rathnasinghe, Raveen, Schotsaert, Michael, Coughlan, Lynda, García-Sastre, Adolfo, Krammer, Florian
Formato: Artigo
Idioma:Inglês
Publicado: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523111/
https://ncbi.nlm.nih.gov/pubmed/32995785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.16.300970
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares